PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 11 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
The aqueous methanolic extract (CAME) and its isolated compounds, specifically vitexin 2"-O-α-l-rhamnopyranoside, were evaluated for cytotoxicity against seven different cancer cell lines via MTT assay [PMID:40685791].
Evidence summary
PubMed sources
- 1.PMID: 40685791 (2025) — The Molecular Mechanisms Underlying the Antineoplastic Profile of Vitexin 2″-O-α-L-Rhamnopyranoside From Cordyline australis (G.Frost.): Isolation and Constituent Profiling. · Archiv der Pharmazie
- 2.PMID: 30823120 (2001) — Association of "Candidatus Phytoplasma australiense" with Sudden Decline of Cabbage Tree in New Zealand. · Plant disease